TP53 and cancer: MDMX depletion induced cell cycle arrest and apoptosis in cancer cells in a partly p53-independent manner [43,44], which could imply that MDMX is not only a valuable therapeutic target in wild-type p53 cancer cells, but also in p53 mutated cells.